Search

Your search keyword '"Vaccines -- Planning"' showing total 4,607 results
Start Over Descriptor "Vaccines -- Planning"
4,607 results on '"Vaccines -- Planning"'

201. Eli Lilly to begin commercial sales of COVID-19 antibody, WSJ reports

Subjects
Eli Lilly and Co. -- Planning, Health care industry -- Planning, Vaccines -- Planning, Monoclonal antibodies, Pharmaceutical industry -- Planning, Health care industry, Company business planning, Business, News, opinion and commentary
Abstract

In a shift away from the way Eli Lilly's drug and most other COVID-19 treatments and vaccines have been distributed in the U.S., the company plans to begin commercial sales [...]

Published
2022

202. Reformulated Booster Shots Ready by September, White House Says

Subjects
Pfizer Inc. -- Planning, Biological products industry -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, Health
Abstract

(HealthDay News) — Americans could be getting updated COVID-19 booster shots that can battle the newest omicron variants as soon as mid-September. People close to deliberations say that the Biden [...]

Published
2022

203. Why Covid experts fear the fall

Subjects
Pfizer Inc. -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning
Abstract

Katherine Wu The Atlantic As new variants arise and we head toward a possible major Covid surge this fall and winter, said Katherine Wu, “the U.S. does not have a [...]

Published
2022

205. Indonesia reinstates booster regime amid growing caseload

Subjects
Vaccines -- Planning, Company business planning, Regional focus/area studies
Abstract

What's happened? From July 17th Indonesians planning to travel between provinces or abroad will be required to present a negative covid-19 test result or proof of having received a booster [...]

Published
2022

206. Pfizer, BioNTech enter new agreement with US govt to provide additional doses of Covid-19 vaccine

Subjects
United States. Food and Drug Administration -- Planning, BioNTech SE -- Planning, Pfizer Inc. -- Planning, Biotechnology industry -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, Pharmaceuticals and cosmetics industries
Abstract

Pfizer Inc. and BioNTech SE announced a new vaccine supply agreement with the US government to support the continued fight against Covid-19. Under the agreement, the US government will receive [...]

Published
2022

207. Valneva says Pfizer to initiate Phase 3 study of VLA15 in third quarter

Subjects
Pfizer Inc. -- Planning, Valneva SE -- Planning, Biotechnology industry -- Planning, Vaccines -- Planning, Lyme disease, Pharmaceutical industry -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

Valneva SE (VALN) and Pfizer (PFE) announced the closing of the equity investment announced on June 20. Pursuant to an equity subscription agreement, Pfizer has invested EUR 90.5M, or $95M, [...]

Published
2022

208. EMA initiates rolling review of Pfizer & BioNTech's variant-adapted version of Covid-19 vaccine

Subjects
United States. Food and Drug Administration -- Planning, BioNTech SE -- Planning, Pfizer Inc. -- Planning, Vaccines -- Planning, Company business planning, Pharmaceuticals and cosmetics industries
Abstract

Pfizer Inc. and BioNTech SE announced the European Medicines Agency (EMA) has initiated a rolling review for a variant-adapted version of the companies' Covid-19 vaccine. This rolling review is initially [...]

Published
2022

209. Canada to end Covid-19 vaccine mandate for domestic air, rail travel

Subjects
Vaccination, Railroads -- Planning, Vaccines -- Planning, Air travel, Company business planning, Travel industry
Abstract

Byline: TBM Staff - Mumbai Canada plans to end Covid-19 vaccine mandates for domestic air and rail travel, as well as outbound international travel, CBC News reported, citing people with [...]

Published
2022

210. BioNTech to provide update on plans for mRNA vaccines in Africa

Subjects
Messenger RNA, Vaccines -- Planning, Company business planning, Business, News, opinion and commentary, African Union -- Planning
Abstract

BioNTech will welcome its African partners for the first time on the African continent and provide an update on the joint establishment of mRNA manufacturing facilities and vaccine development plans. [...]

Published
2022

211. J&J to end Covid-19 vaccine deal with Emergent BioSolutions, WSJ reports

Subjects
Johnson & Johnson -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

Johnson & Johnson (JNJ) plans to end its Covid-19 vaccine supply deal with Emergent BioSolutions (EBS) as both companies accused each other of breaching the deal, The Wall Street Journal's [...]

Published
2022

212. UK could be forced into lockdown under WHO treaty

Subjects
Vaccines -- Planning, Company business planning, General interest
Abstract

Byline: Tony Diver Whitehall Correspondent LOCKDOWN measures could be imposed on the UK by the World Health Organisation during a future pandemic under sweeping new powers, ministers fear. Member states [...]

Published
2023

213. Moderna expands to PHL via enterprise solutions hub

Subjects
Moderna Inc. -- Planning, Biological products industry -- Planning, Biotechnology industry -- Planning, Vaccines -- Planning, Company business planning, Business, international
Abstract

Moderna Inc., a United States-based vaccine manufacturer, has announced plans to establish an enterprise solutions hub in the Philippines. Stephane Bancel, CEO of Moderna said the company is expanding its [...]

Published
2023

214. Tycoon's 'Unvaxxed Sperm' Auction Taps Into Conspiracies

Subjects
Auctions -- Planning, Fraud, Spermatozoa, Vaccines -- Planning, Conspiracy theories, Company business planning, Business, international, News, opinion and commentary
Abstract

A fugitive Chinese billionaire plans to auction 'unvaccinated sperm' on an online platform rife with misinformation -- a sale that vaccine skeptics bill optimistically as a chance to buy the [...]

Published
2023

215. Alibaba's Overhaul: A 'Smart' Move After China Crackdown

Subjects
Ant Group Company Ltd. -- Planning, High technology industry, Computer services industry -- Planning, Vaccines -- Planning, Company business planning, Computer services industry, Business, international, News, opinion and commentary
Abstract

Alibaba, China's biggest e-commerce company, has announced plans to split its business into six groups, in one of the most significant overhauls of a leading Chinese tech firm to date. [...]

Published
2023

216. How GSK Plans To Replenish Its Depleted Medicine Cabinet

Subjects
AstraZeneca PLC -- Planning, Respiratory agents, Hepatitis B, Vaccines -- Planning, Company business planning, Business, international, News, opinion and commentary
Abstract

GSK's chief scientist says an overhaul of the drugmaker's R&D unit has begun delivering results - citing an RSV vaccine and promising hepatitis B and asthma treatments - and pledged [...]

Published
2023

217. Plan to make mRNA vaccines in developing countries needs U.S. funding, backers say

Subjects
Messenger RNA, Developing countries, Public health, Vaccines -- Planning, Coronaviruses, Company business planning, Company financing, Business, Computers and office automation industries, Telecommunications industry, World Bank Group. World Bank -- Planning, World Health Organization -- Planning
Abstract

Byline: Adam Taylor CORRECTION: An earlier version of this article said the World Bank's pandemic fund had raised $300 million. It has raised some $1.6 billion, with $300 million available [...]

Published
2023

218. Novavax Raises Doubts About Its Ability To Remain In Business

Subjects
Novavax Inc. -- Finance, Biological products industry -- Planning -- Finance, Vaccination, Biotechnology industry -- Finance -- Planning, Vaccines -- Planning, Company business planning, Company financing, Business, international, News, opinion and commentary
Abstract

COVID-19 vaccine maker Novavax Inc on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall [...]

Published
2023

219. Dozens of Children Among 36 Killed at Nursery School; Concerns Grow Over Putin's Nuclear Saber-Rattling; UK May Face Power Cuts Without European Energy Imports; Uganda faces Ebola Outbreak; White House in the Dark About Kim's Motives; Source: the U.S. Lacks Intel To Predict North Korea's Action; Florida Residents Frustrated With State And Federal Response; Cuba's Famous Tobacco Growers Facing A Long Recovery. Aired 2-2:45a ET

Subjects
Cable News Network. CNN International -- International economic relations, Hurricane Ian, 2022 -- Planning, Tobacco industry -- International economic relations, School violence, Prime ministers -- Planning, Ebola virus infections, Power failure, Vaccines -- Planning, Farmers -- Planning, Company business planning, News, opinion and commentary
Abstract

[02:00:00] KIM BRUNHUBER, CNN ANCHOR: Welcome to all of you watching us all around the world live from CNN world headquarters in Atlanta. I'm Kim Brunhuber. This is 'CNN Newsroom.' [...]

Published
2022

221. FDA begins transitioning COVID-19 tests to normal channels

Subjects
United States. Food and Drug Administration -- Planning, Vaccines -- Planning, Company business planning, Law
Abstract

The Food and Drug Administration on Tuesday announced it will limit future emergency authorizations for COVID-19 tests in a bid to transition reviews back to normal approval channels. The move [...]

Published
2022

222. Moderna, Takeda announce plan to transfer Spikevax authorization in Japan

Subjects
Vaccines -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

Moderna (MRNA) and Takeda (TAK) announced plans to transfer the marketing authorization in Japan for Moderna's COVID-19 vaccine Spikevax from Takeda to Moderna in Japan as of August 1. Moderna [...]

Published
2022

223. NIH Launches Clinical Trial of Epstein-Barr Virus Vaccine

Subjects
United States. National Institutes of Health -- Planning, United States. National Institute of Allergy and Infectious Diseases -- Planning, Medical research, Medicine, Experimental, Clinical trials, Vaccines -- Planning, Epstein-Barr virus, Company business planning, Health
Abstract

HealthDay News — The US National Institutes of Health are launching an early-stage clinical trial to evaluate a potential vaccine for Epstein-Barr virus (EBV). The study will evaluate the safety [...]

Published
2022

224. FDA announces tentative advisory committee meetings on COVID-19 vaccines

Subjects
United States. Food and Drug Administration -- Planning, Biological products industry -- Planning, Meetings, Vaccines -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

On Friday, the U.S. Food and Drug Administration is announcing its plans to hold virtual meetings of its Vaccines and Related Biological Products Advisory Committee, or VRBPAC, in anticipation of [...]

Published
2022

225. FDA Panel Will Meet to Discuss Multiple COVID-19 Vaccine EUA Requests

Author

Park, Brian

Subjects
United States. Food and Drug Administration -- Planning, Pfizer Inc. -- Planning, Vaccines -- Planning, Company business planning, Health
Abstract

The Food and Drug Administration (FDA) plans to hold virtual meetings of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) in anticipation of Emergency Use Authorization (EUA) requests in [...]

Published
2022

226. Moderna finalizes plan for strategic partnership with Government of Canada

Subjects
Vaccines -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

Moderna announced its plan to build a state-of-the-art mRNA vaccine manufacturing facility in Quebec that will support a long-term strategic partnership with the Government of Canada to enhance pandemic preparedness. [...]

Published
2022

227. Biden administration plans to offer second booster shots for some, NYT reports

Subjects
Pfizer Inc. -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

The Biden administration plans to offer Americans age 50 or older the option of a second booster of the Pfizer (PFE)-BioNTech (BNTX) or Moderna (MRNA) Covid-19 vaccine, though it will [...]

Published
2022

228. Eiger BioPharmaceuticals' COVID-19 vaccine shows 50% hospitalization reduction

Subjects
Interferon -- Planning, Biopharmaceutics -- Planning, Vaccines -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

Eiger BioPharmaceuticals announced that Peginterferon Lambda significantly reduced the risk of COVID-19-related hospitalizations or emergency room visits greater than six hours by 50% - primary endpoint - and death by [...]

Published
2022

229. Pfizer to seek second shot authorization for 65 and older, Washington Post says

Subjects
United States. Food and Drug Administration -- Planning, Pfizer Inc. -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

Pfizer (PFE) and BioNTech (BNTX) will seek emergency authorization for a second booster shot of their coronavirus vaccine for people 65 and older, Laurie McGinley, Tyler Pager and Carolyn Johnson [...]

Published
2022

230. Pfizer to seek emergency authorization for second booster, Washington Post says

Subjects
United States. Food and Drug Administration -- Planning, Pfizer Inc. -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

Pfizer (PFE) and BioNTech (BNTX) will seek emergency authorization for a second booster shot of their coronavirus vaccine for people 65 Laurie McGinley, Tyler Pager and Carolyn Johnson of Washington [...]

Published
2022

231. Moderna to establish Enterprise Solutions Hub in Atlanta, Georgia

Subjects
Moderna Inc. -- Planning, RNA, Vaccines -- Planning, Company business planning, Pharmaceuticals and cosmetics industries
Abstract

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced plans to establish an Enterprise Solutions Hub in Atlanta, Georgia. Moderna's Atlanta office will initially host finance, [...]

Published
2022

233. BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update

Subjects
United States. Food and Drug Administration -- Planning, Pfizer Inc. -- Company sales and earnings, Viral antibodies, Vaccines -- Planning, Antibodies, Pharmaceutical industry -- Company sales and earnings, Company business planning, Company earnings/profit, Banking, finance and accounting industries, Business
Abstract

Significant pipeline advancement highlighted by the initiation of BNT316/ONC-392 Phase 3 pivotal trial and multiple trials planned to start across the oncology portfolio Positive data updates across multiple technology platforms [...]

Published
2023

234. Canada : Government of Canada announces plans to create a vaccine bank for Foot and Mouth Disease in animals

Subjects
Canada. Canadian Food Inspection Agency -- Planning, Epidemics -- Canada, Banks (Finance) -- Planning, Foot-and-mouth disease, Cabinet officers -- Planning, Vaccines -- Planning, Company business planning, Business, international
Abstract

Today, as part of the annual conference of Federal, Provincial and Territorial (FPT) Ministers of Agriculture, Ministers confirmed their commitment to respond to animal disease outbreaks through the establishment of [...]

Published
2023

235. YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023

Subjects
Biological products industry -- Company sales and earnings, Vaccines -- Planning, Company business planning, Company earnings/profit, Business, News, opinion and commentary
Abstract

GAITHERSBURG, Md., July 21, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ('YS Biopharma' or the 'Company'), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new [...]

Published
2023

236. GOVERNMENT OF CANADA ANNOUNCES PLANS TO CREATE A VACCINE BANK FOR FOOT AND MOUTH DISEASE IN ANIMALS

Subjects
Canada. Canadian Food Inspection Agency -- Planning, Epidemics -- Canada, Banks (Finance) -- Planning, Foot-and-mouth disease, Vaccines -- Planning, Company business planning, News, opinion and commentary
Abstract

OTTAWA, Canada -- The following information was released by the Government of Canada: July 20, 2023 - New Brunswick Today, as part of the annual conference of Federal, Provincial and [...]

Published
2023

237. United States : Daines to Introduce Amendments to Fy2024 NDAA to Bolster National Security, Support Montana Service Members

Subjects
Bills, Legislative, International trade, Espionage, Vaccines -- Planning, Military bases, Company business planning, International trade, Business, international
Abstract

U.S. Senator Steve Daines today released the list of amendments he plans to introduce next week as part of the National Defense Authorization Act (NDAA), including legislation to crack down [...]

Published
2023

238. First on CNN: Updated Covid shot should be ready by 'latter part of September,' HHS secretary says in letter to manufacturers

Subjects
United States. Centers for Disease Control and Prevention -- Planning, United States. Department of Health and Human Services -- Planning, Pfizer Inc. -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, General interest, News, opinion and commentary
Abstract

Byline: Jacqueline Howard, CNN (CNN) -- (CNN) — US health officials are moving forward with plans to sunset the federal government's Covid-19 vaccine distribution program next month and move the [...]

Published
2023

239. Chinese medical manufacturer plans Sh9.84bn plant in Kenya

Subjects
Vaccines -- Planning, Company business planning, News, opinion and commentary, World Bank Group. International Finance Corporation -- Planning
Abstract

Zhende Limited, a Chinese medical supplies manufacturer, plans to build two plants in Kenya after securing Sh9.84 billion in funding from the International Finance Corporation (IFC).The Shanghai Stock Exchange-listed firm [...]

Published
2023

242. Walgreens is Closing 150 Stores; Everyone Should Worry

Subjects
Walgreen Co. -- Facility closures, Drugstores -- Facility closures, Vaccines -- Planning, Company business planning, Business
Abstract

To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: https://www.thestreet.com/retailers/walgreens-is-closing-150-stores-everyone-should-worry Closing stores is a fact of life for retailers. But some closings should [...]

Published
2023

244. Foreign travel advice Nepal Dated: 21-06-23

Subjects
Travel industry -- Planning, Vaccines -- Planning, Company business planning, Business, international
Abstract

London: UK Government has issued the following news release: Summary Still current at: 21 June 2023 Updated: 21 June 2023 Latest update: Government of Nepal has removed the requirement for [...]

Published
2023

245. Holland & Knight Health Dose: June 6, 2023

Subjects
Holland & Knight L.L.P. -- Planning, Law firms -- Planning, Vaccines -- Planning, Company business planning, Business, international
Abstract

Holland & Knight Health Doseis an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics [...]

Published
2023

247. China's Vaccine Benefits the World: 44 foreign media reporters visited SINOVAC

Subjects
Sinovac Biotech Ltd. -- International economic relations, Biological products industry -- International economic relations, Hepatitis A, Diagnostic reagents -- Planning, Journalists -- Planning, Vaccines -- Planning, Company business planning, Business, Business, international
Abstract

On October 31, 2023, 50 foreign media reporters from 44 countries visited SINOVAC. Sinovac has supplied 5 vaccines, including COVID-19, to 62 'Belt and Road' countries, totaling over 1.2 billion [...]

Published
2023

248. Vaxcyte receives FDA clearance for VAX-31 IND application aimed at preventing invasive pneumococcal disease in adults

Subjects
United States. Food and Drug Administration -- Planning, Clinical trials, Adults -- Planning, Vaccines -- Planning, Company business planning, Business
Abstract

M2 EQUITYBITES-October 19, 2023-Vaxcyte receives FDA clearance for VAX-31 IND application aimed at preventing invasive pneumococcal disease in adults (C)2023 M2 COMMUNICATIONS http://www.m2.co.uk Vaccine developer Vaxcyte Inc (Nasdaq:PCVX) announced on [...]

Published
2023

249. Vaxcyte receives FDA clearance for VAX-31 IND application aimed at preventing invasive pneumococcal disease in adults

Subjects
United States. Food and Drug Administration -- Planning, Clinical trials, Adults -- Planning, Vaccines -- Planning, Company business planning, Chemistry
Abstract

M2 PHARMA-October 19, 2023-Vaxcyte receives FDA clearance for VAX-31 IND application aimed at preventing invasive pneumococcal disease in adults (C)2023 M2 COMMUNICATIONS Vaccine developer Vaxcyte Inc (Nasdaq:PCVX) announced on Thursday [...]

Published
2023

250. Biden can point to a coming milestone: the end of the Covid public health emergency

Author

Stolberg, Sheryl Gay

Subjects
Public health, Vaccines -- Planning, Company business planning, News, opinion and commentary
Abstract

The move is a public acknowledgment that Covid-19 is now part of the ordinary fabric of American life but also carries important practical consequences. Three years after the coronavirus upended [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results